| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $141K | — | +95.8% |
| R&D Expense | $77.6M | — | +1.0% |
| SG&A Expense | $38.7M | — | +126.2% |
| Operating Income | -$116.2M | — | -23.8% |
| Net Income | -$104.9M | — | -20.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $784.7M | -12.2% | +19.4% |
| Total Assets | $789.0M | -12.3% | +19.4% |
| Current Liabilities | $51.8M | -26.7% | +53.6% |
| Total Liabilities | $153.0M | -13.7% | +170.8% |
| Stockholders' Equity | $636.0M | -11.9% | +5.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$119.7M | — | -29.1% |
| Capital Expenditures | $23K | — | -73.3% |
| Investing Cash Flow | $77.3M | — | -22.8% |
| Financing Cash Flow | $6.4M | — | -31.0% |
| Free Cash Flow | -$119.7M | — | -29.0% |